Your Partner for Growth, Hybridan

Hybridan

Your Partner for Growth

Our passion is raising growth capital for exciting, fast growth companies that want to take their business to the next level. We raise capital for companies both listed and unlisted in the most efficient manner possible and pride ourselves as being one of the few consistently profitable broking firms in the City. This has been achieved through a highly disciplined approach when seeking to create both corporate and institutional relationships.

Equity Bottom-Up

<ul>
<li>Abingdon Health 6.25p £11.71m (ABDX.L) The international developer, manufacturer and regulatory services provider for rapid diagnostic tests and medtech announces that, further to its announcement yesterday, it has completed and closed the placing to raise gross proceeds of £3.3m.</li>
<li>As part of the Placing, Chris Hand, Executive Chairman of the Company, has agreed to subscribe for £30k.</li>
<li>In addition to the Placing, the Company is providing existing eligible shareholders with the opportunity to subscribe for Retail Offer Shares at the Placing Price, to raise up to £200k. </li>
</ul>


Abingdon Health 6.25p £11.71m (ABDX.L) The international developer, manufacturer and regulatory services provider for rapid diagnostic tests and medtech announces that, further to its announcement yesterday, it has completed and closed the placing to raise gross proceeds of £3.3m.
As part of the Placing, Chris Hand, Executive Chairman of the Company, has agreed to subscribe for £30k.
In addition to the Placing, the Company is providing existing eligible shareholders with the opportunity to subscribe for Retail Offer Shares at the Placing Price, to raise up to £200k. 


Sosandar PLC - Hybridan Small Cap Feast: 14/10/2025

<ul>
<li>Our daily digest of news from UK Small Caps 1st September 2025 @HybridanLLP * A corporate client of Hybridan LLP.</li>
<li>Potential means Intention to Float (ITF) or similar announcement has been made.</li>
<li>Arranged by type of listing and date of announcement.</li>
</ul>


Our daily digest of news from UK Small Caps 1st September 2025 @HybridanLLP * A corporate client of Hybridan LLP.
Potential means Intention to Float (ITF) or similar announcement has been made.
Arranged by type of listing and date of announcement.


World Chess PLC - Hybridan Small Cap Feast: 01/09/2025

iFOREX Financial Trading / Equity Bottom-Up

<ul>
<li>Updated 10th June: iFOREX Financial Trading, the fintech business with a proprietary online and mobile trading platform for multi-asset contracts for difference, announced that its proposed IPO onto the Main Market, which was expected to occur in late June, will be briefly delayed.</li>
<li>A routine thematic compliance inspection commenced earlier this year in the BVI, which was disclosed in the Company's Registration Document, requires additional time to enable finalisation ahead of the IPO.</li>
<li>The inspection process is close to completion and the Company anticipates only a short delay to the IPO timetable. </li>
</ul>


Updated 10th June: iFOREX Financial Trading, the fintech business with a proprietary online and mobile trading platform for multi-asset contracts for difference, announced that its proposed IPO onto the Main Market, which was expected to occur in late June, will be briefly delayed.
A routine thematic compliance inspection commenced earlier this year in the BVI, which was disclosed in the Company's Registration Document, requires additional time to enable finalisation ahead of the IPO.
The inspection process is close to completion and the Company anticipates only a short delay to the IPO timetable. 


<ul>
<li>12th May: Cobalt Holdings, a Company created primarily to purchase and hold physical cobalt, offering public equity investors pure-play direct exposure to the price of cobalt, confirmed its intention to raise approximately US$230m through its Global Offer and the Admission on to the Main Market on 10 June 2025.</li>
<li>Glencore International AG and certain entities and affiliates managed by Anchorage Structured Commodities Advisor, have agreed to participate as cornerstone investors, agreeing to invest, in aggregate, an amount representing approximately 20.5% of the Shares to be offered pursuant to the Global Offer.</li>
<li>9th May: iFOREX Financial Trading, the fintech business with a proprietary online and mobile trading platform for multi-asset contracts for difference, announces that it has confirmed its intention to IPO onto the Main Market.</li>
</ul>


12th May: Cobalt Holdings, a Company created primarily to purchase and hold physical cobalt, offering public equity investors pure-play direct exposure to the price of cobalt, confirmed its intention to raise approximately US$230m through its Global Offer and the Admission on to the Main Market on 10 June 2025.
Glencore International AG and certain entities and affiliates managed by Anchorage Structured Commodities Advisor, have agreed to participate as cornerstone investors, agreeing to invest, in aggregate, an amount representing approximately 20.5% of the Shares to be offered pursuant to the Global Offer.
9th May: iFOREX Financial Trading, the fintech business with a proprietary online and mobile trading platform for multi-asset contracts for difference, announces that it has confirmed its intention to IPO onto the Main Market.


Trellus Health Plc - Hybridan Small Cap Feast: 02/06/2025

<ul>
<li>The developer, manufacturer, and distributor of high quality and effective rapid tests reports interim results to December 2024.</li>
<li>Financial highlights include a £5.2m placing, a 28% increase in Revenue to £3.1m, but with an Operating loss of £2.6m up from a loss of £1.2m in H123 as a result of investments in growth initiatives.</li>
<li>The adjusted EBITDA loss was £1.9m and an improved EBITDA performance is expected in H2 due to forecast revenue growth as key strategic milestones are passed, such as the acquisition of CS Lifesciences, the opening of Abingdon Analytical in Doncaster, and the commencement of work in April from the new US site. </li>
</ul>


The developer, manufacturer, and distributor of high quality and effective rapid tests reports interim results to December 2024.
Financial highlights include a £5.2m placing, a 28% increase in Revenue to £3.1m, but with an Operating loss of £2.6m up from a loss of £1.2m in H123 as a result of investments in growth initiatives.
The adjusted EBITDA loss was £1.9m and an improved EBITDA performance is expected in H2 due to forecast revenue growth as key strategic milestones are passed, such as the acquisition of CS Lifesciences, the opening of Abingdon Analytical in Doncaster, and the commencement of work in April from the new US site. 


Duplicate of Hybridan Small Cap Feast: 24/03/2025

United Kingdom

Abingdon Health is an international developer, manufacturer, and distributor of lateral flow assay diagnostic tests, also known as rapid tests. The company provides comprehensive contract development and manufacturing (CDMO) services for rapid diagnostics across various sectors, including healthcare, animal health, and environmental testing. Abingdon Health is headquartered in York, England, and was founded in 2008.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Abingdon Health (ABDX LN)

Sosandar PLC - Hybridan Small Cap Feast: 14/10/2025

In addition to the Placing, the Company is providing existing eligible shareholders with the opportunity to subscribe for Retail Offer Shares at...

Hybridan

World Chess PLC - Hybridan Small Cap Feast: 01/09/2025

Our daily digest of news from UK Small Caps 1st September 2025 @HybridanLLP * A corporate client...

Hybridan

Hybridan Small Cap Feast: 12/06/2025

iFOREX Financial Trading, the fintech business with a proprietary online and mobile trading platform for multi-asset contracts for difference...

Hybridan

Trellus Health Plc - Hybridan Small Cap Feast: 02/06/2025

Cobalt Holdings, a Company created primarily to purchase and hold physical cobalt, offering public equity investors pure-play direct exposure to...

Hybridan

Duplicate of Hybridan Small Cap Feast: 24/03/2025

The developer, manufacturer, and distributor of high quality and effective rapid tests reports interim results to December 2024.

Hybridan

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)